en
Scientific article
English

EASL Recommendations on Treatment of Hepatitis C 2018

ContributorsEuropean Association for the Study of the Liver
CollaboratorsNegro, Francesco
Published inJournal of Hepatology, vol. 69, no. 2, p. 461-511
Publication date2018
Abstract

Hepatitis C virus (HCV) infection is a major cause of chronic liver disease, with approximately 71 million chronically infected individuals worldwide. Clinical care for patients with HCV-related liver disease has advanced considerably thanks to an enhanced understanding of the pathophysiology of the disease, and because of developments in diagnostic procedures and improvements in therapy and prevention. These European Association for the Study of the Liver Recommendations on Treatment of Hepatitis C describe the optimal management of patients with acute and chronic HCV infections in 2018 and onwards.

Keywords
  • Acute Disease
  • Chronic Disease
  • Diagnostic Screening Programs/organization & administration
  • Hepatitis C/diagnosis/physiopathology/therapy
  • Humans
  • Patient Care Management/methods/standards
  • Risk Assessment
  • Risk Factors
Citation (ISO format)
European Association for the Study of the Liver. EASL Recommendations on Treatment of Hepatitis C 2018. In: Journal of Hepatology, 2018, vol. 69, n° 2, p. 461–511. doi: 10.1016/j.jhep.2018.03.026
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal0168-8278
260views
0downloads

Technical informations

Creation11/07/2019 5:12:00 PM
First validation11/07/2019 5:12:00 PM
Update time03/15/2023 6:18:25 PM
Status update03/15/2023 6:18:25 PM
Last indexation01/17/2024 6:43:52 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack